# Resection Margin of Transverse Colon Cancer With Extracorporeal Versus Intracorporeal Anastomosis

> **NCT05061199** · — · COMPLETED · sponsor: **Shanghai Minimally Invasive Surgery Center** · enrollment: 480 (actual)

## Conditions studied

- Transverse Colon Cancer

## Interventions

- **PROCEDURE:** approach of anastomosis

## Key facts

- **NCT ID:** NCT05061199
- **Lead sponsor:** Shanghai Minimally Invasive Surgery Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 480 (ACTUAL)
- **Last updated:** 2024-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05061199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05061199, "Resection Margin of Transverse Colon Cancer With Extracorporeal Versus Intracorporeal Anastomosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05061199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*